SCHEMBL809430

SCHEMBL809430

CC(Cl)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27464185 1.00
SCHEMBL502128 0.73
1,1,2,2-Tetrachloroethane SCHEMBL17844299 0.72 TDP1 (0.36)
1,2-Dibromoethane SCHEMBL29029880 0.72
SCHEMBL1130066 0.72
SCHEMBL4730315 0.70
SCHEMBL7399 0.70
SCHEMBL1038821 0.70
SCHEMBL9805300 0.70
SCHEMBL7725 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 260 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115772176-A Synthetic method of key drug intermediate of levofloxacin 常州兰陵制药有限公司 2023-03-10 CN claimed
WO-2013171755-A2 \"COMBUSTION SYNTHESIS OF NANOCRYSTALLINE ALKALI AND ALKALINE EARTH METAL OXIDES OR MIXTURE THEREOF AND ITS APPLICATIONS IN SYNTHESIS OF [4- (ALKYL/ARYL)-OXY- 1,3 -DIOXOLANE-2- ONE] AND 2-OXAZOLIDINONES\ YADAV GANAPATI DADASAHEB (IN) 2013-11-21 WO claimed
EP-0813609-B1 METHOD OF NUCLEIC ACID ANALYSIS CANCER REC TECH LTD (GB) 2004-10-13 EP claimed
US-6268129-B1 MASS SPECTROMETRY OF CHARGED NUCLEIC ACID; DNA SEQUENCING IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2001-07-31 US claimed
US-5871670-A Electroconductive composition CIBA SPECIALTY CHEMICALS CORPORATION (US) 1999-02-16 US claimed
EP-0813609-A1 METHOD OF NUCLEIC ACID ANALYSIS IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) 1997-12-29 EP claimed
EP-0782750-A1 NOVEL ELECTROCONDUCTIVE COMPOSITION Ciba SC Holding AG (CH) 1997-07-09 EP claimed
WO-1996027681-A1 METHOD OF NUCLEIC ACID ANALYSIS IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) 1996-09-12 WO claimed
WO-1996009629-A1 NOVEL ELECTROCONDUCTIVE COMPOSITION CIBA SPECIALTY CHEMICALS HOLDIING INC (CH) 1996-03-28 WO claimed
EP-0362141-B1 Electrically conductive support and polymer films, and process for manufacturing the same CIBA GEIGY AG (CH) 1995-11-15 EP claimed
EP-0362143-B1 Antistatic and electrically conductive relief images, process for manufacturing the same, coating material and radiation-sensitive polymers CIBA GEIGY AG (CH) 1995-11-15 EP claimed
EP-0521826-B1 Process for the production of electroconductive layers CIBA GEIGY AG (CH) 1995-06-07 EP claimed
US-5348762-A Process for the production of conductive layers CIBA-GEIGY CORPORATION (US) 1994-09-20 US claimed
EP-0521826-A1 Process for the production of electroconductive layers CIBA-GEIGY AG (CH) 1993-01-07 EP claimed
EP-0285564-B1 ANTISTATIC AND ELECTRICALLY CONDUCTIVE POLYMERS AND MOULDING COMPOSITIONS CIBA-GEIGY AG (CH) 1992-04-15 EP claimed
US-5096780-A ELECTRICALLY CONDUCTIVE COATING COMPRISING A NEEDLE NETWORK OF CHANGE TRANSFER COMPLEXES CIBA-GEIGY CORPORATION (US) 1992-03-17 US claimed
US-5009812-A Forming charge transfer complexes CIBA-GEIGY CORPORATION (US) 1991-04-23 US claimed
EP-0362143-A2 Antistatic and electrically conductive relief images, process for manufacturing the same, coating material and radiation-sensitive polymers CIBA-GEIGY AG (CH) 1990-04-04 EP claimed
EP-0285564-A1 Antistatic and electrically conductive polymers and moulding compositions CIBA-GEIGY AG (CH) 1988-10-05 EP claimed
US-12478612-B2 Deuterated domperidone compositions, methods, and preparation CINDOME PHARMA, INC. (US) 2025-11-25 US disclosed
US-20250312490-A1 SYSTEMIC DELIVERY OF MYOSTATIN SHORT INTERFERING NUCLEIC ACIDS (SINA) CONJUGATED TO A LIPOPHILIC MOIETY BANK OF AMERICA, N.A. 2025-10-09 US disclosed
CN-116082317-B Selenium-containing coumarin derivative, preparation method thereof and application thereof in preparation of antitumor drugs 浙江工业大学 2025-04-15 CN disclosed
CN-119285809-A Functional hyaluronic acid derivative and preparation method and application thereof 华熙生物科技股份有限公司 2025-01-10 CN disclosed
US-20240383854-A1 PROCESS FOR THE PREPARATION OF CHLOROALKYL SUBSTITUTED CYCLIC AMINES HOVIONE FARMACIENCIA SA (PT) 2024-11-21 US disclosed
EP-4392411-A1 PROCESS FOR THE PREPARATION OF CHLOROALKYL SUBSTITUTED CYCLIC AMINES Hovione Farmaciencia SA (PT) 2024-07-03 EP disclosed
EP-3532580-B1 USE AND METHOD COMPRISING A LUBRICATING OIL COMPOSITIONS COMPRISING BIODIESEL FUEL AND A DISPERSANT CHEVRON ORONITE TECH BV (NL) 2024-07-03 EP disclosed
CN-118159526-A Process for preparing chloroalkyl substituted cyclic amines 好利安药理股份公司 2024-06-07 CN disclosed
US-20240091199-A1 Deuterated Domperidone Compositions, Methods, and Preparation CINDOME PHARMA, INC. (US) 2024-03-21 US disclosed
CN-116712432-A Deuterated domperidone compositions, methods and preparations 辛多美制药有限公司 2023-09-08 CN disclosed
CN-111093653-B Deuterated domperidone compositions, methods and preparations 辛多美制药有限公司 2023-06-23 CN disclosed
US-20230144623-A1 SYSTEMIC DELIVERY OF MYOSTATIN SHORT INTERFERING NUCLEIC ACIDS (SINA) CONJUGATED TO A LIPOPHILIC MOIETY SIRNA THERAPEUTICS, INC. 2023-05-11 US disclosed
CN-116082317-A Selenium-containing coumarin derivative, preparation method thereof and application thereof in preparation of antitumor drugs 浙江工业大学 2023-05-09 CN disclosed
CN-115772176-A Synthetic method of key drug intermediate of levofloxacin 常州兰陵制药有限公司 2023-03-10 CN disclosed
WO-2023030667-A1 PROCESS FOR THE PREPARATION OF CHLOROALKYL SUBSTITUTED CYCLIC AMINES HOVIONE SCIENTIA (IE) 2023-03-09 WO disclosed
US-11529428-B2 Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety BANK OF AMERICA, N.A. 2022-12-20 US disclosed
CN-114921560-A Noninvasive biomarkers for hepatic fibrosis and liver cancer 广西医科大学 2022-08-19 CN disclosed
CN-114921559-A Application of GPNMB gene as noninvasive biomarker in preparation of products for diagnosing hepatic fibrosis and liver cancer diseases 广西医科大学 2022-08-19 CN disclosed
US-11364226-B2 Deuterated domperidone compositions, methods, and preparation CINRX PHARMA, LLC (US) 2022-06-21 US disclosed
CN-109414013-B Having an anion C6-C10Agroformulation of co-dispersant microcapsules 巴斯夫欧洲公司 2021-11-12 CN disclosed
EP-3610884-B1 PEPTIDE CONTAINING CONJUGATES FOR DUAL MOLECULAR DELIVERY OF OLIGONUCLEOTIDES MERCK SHARP & DOHME (US) 2021-08-18 EP disclosed
US-20210137892-A1 Deuterated Domperidone Compositions, Methods, and Preparation CINRX PHARMA, LLC (US) 2021-05-13 US disclosed
WO-2021086067-A1 BIOMARKERS IN SALIVA FOR DIAGNOSING ORAL CANCER 경북대학교 산학협력단 2021-05-06 WO disclosed
US-20210008226-A1 SYSTEMIC DELIVERY OF MYOSTATIN SHORT INTERFERING NUCLEIC ACIDS (SINA) CONJUGATED TO A LIPOPHILIC MOIETY BANK OF AMERICA, N.A. 2021-01-14 US disclosed
US-10729787-B2 Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety SIRNA THERAPEUTICS, INC. (US) 2020-08-04 US disclosed
EP-3644995-A1 DEUTERATED DOMPERIDONE COMPOSITIONS, METHODS, AND PREPARATION CinDome Pharma, Inc. (US) 2020-05-06 EP disclosed
CN-111093653-A Deuterated domperidone composition, method and preparation 辛多美制药有限公司 2020-05-01 CN disclosed
US-10590110-B2 Deuterated domperidone compositions, methods, and preparation CinDome Pharma, LLC (US) 2020-03-17 US disclosed
EP-3610884-A1 PEPTIDE CONTAINING CONJUGATES FOR DUAL MOLECULAR DELIVERY OF OLIGONUCLEOTIDES MERCK SHARP & DOHME CORP. (US) 2020-02-19 EP disclosed
EP-3065758-B1 PEPTIDE CONTAINING CONJUGATES FOR DUAL MOLECULAR DELIVERY OF OLIGONUCLEOTIDES MERCK SHARP & DOHME (US) 2019-09-25 EP disclosed
EP-3532580-A1 LUBRICATING OIL COMPOSITIONS COMPRISING A BIODIESEL FUEL AND A DISPERSANT Chevron Oronite Technology B.V. (NL) 2019-09-04 EP disclosed
US-20190241543-A1 DEUTERATED DOMPERIDONE COMPOSITIONS, METHODS, AND PREPARATION CINRX PHARMA, LLC 2019-08-08 US disclosed
US-10344245-B2 Lubricating oil compositions comprising a biodiesel fuel and a dispersant CHEVRON ORONITE TECHNOLOGY B.V. (NL) 2019-07-09 US disclosed
EP-2686441-B1 METHODS AND USES FOR PREDICTING RESPONSE TO ERIBULIN EISAI R&D MAN CO LTD (JP) 2019-05-08 EP disclosed
US-10266516-B2 Deuterated domperidone compositions, methods, and preparation CINRX PHARMA, LLC (US) 2019-04-23 US disclosed
US-10239957-B2 Peptide containing conjugates for dual molecular delivery of oligonucleotides MERCK SHARP & DOHME CORP. (US) 2019-03-26 US disclosed
US-20190015442-A1 DUAL MOLECULAR DELIVERY OF OLIGONUCLEOTIDES AND PEPTIDE CONTAINING CONJUGATES MERCK SHARP & DOHME CORP. (US) 2019-01-17 US disclosed
WO-2019006078-A1 DEUTERATED DOMPERIDONE COMPOSITIONS, METHODS, AND PREPARATION CINRX PHARMA, LLC (US) 2019-01-03 WO disclosed
US-10010562-B2 Dual molecular delivery of oligonucleotides and peptide containing conjugates MERCK SHARP & DOHME CORP. (US) 2018-07-03 US disclosed
EP-2271733-B1 A LUBRICATING OIL ADDITIVE COMPOSITION AND METHOD OF MAKING THE SAME CHEVRON ORONITE CO (US) 2018-06-27 EP disclosed
EP-1717300-B1 A lubricating oil additive composition and method of making the same CHEVRON ORONITE CO (US) 2018-06-27 EP disclosed
US-10004814-B2 Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety SIRNA THERAPEUTICS, INC. (US) 2018-06-26 US disclosed
US-20180148418-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-31 US disclosed
WO-2018077621-A1 LUBRICATING OIL COMPOSITIONS COMPRISING A BIODIESEL FUEL AND A DISPERSANT CHEVRON ORONITE TECHNOLOGY B.V. (NL) 2018-05-03 WO disclosed
WO-2018078005-A1 AMIDO-SUBSTITUTED AZASPIRO DERIVATIVES AS TANKYRASE INHIBITORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-03 WO disclosed
US-20180112145-A1 LUBRICATING OIL COMPOSITIONS COMPRISING A BIODIESEL FUEL AND A DISPERSANT CHEVRON ORONITE TECHNOLOGY B.V. (NL) 2018-04-26 US disclosed
EP-3292107-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES Bayer Pharma Aktiengesellschaft (DE) 2018-03-14 EP disclosed
US-20170298046-A1 DEUTERATED DOMPERIDONE COMPOSITIONS, METHODS, AND PREPARATION CINDOME PHARMA, INC. 2017-10-19 US disclosed
US-20170189441-A1 DUAL MOLECULAR DELIVERY OF OLIGONUCLEOTIDES AND PEPTIDE CONTAINING CONJUGATES MERCK SHARP & DOHME CORP. (US) 2017-07-06 US disclosed
US-9637795-B2 Methods and compositions for predicting response to eribulin EISAI R&D MANAGEMENT CO., LTD. (JP) 2017-05-02 US disclosed
US-20170081425-A1 PEPTIDE CONTAINING CONJUGATES FOR DUAL MOLECULAR DELIVERY OF OLIGONUCLEOTIDES MERCK SHARP & DOHME CORP. (US) 2017-03-23 US disclosed
WO-2016177658-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-11-10 WO disclosed
EP-3087155-A1 CONTROL OF SUSTAINED CASING PRESSURE IN WELLBORE ANNULI Albemarle Corporation (US) 2016-11-02 EP disclosed
US-20160289527-A1 CONTROL OF SUSTAINED CASING PRESSURE IN WELLBORE ANNULI ALBEMARLE CORP (US) 2016-10-06 US disclosed
EP-3068407-A1 SYSTEMIC DELIVERY OF MYOSTATIN SHORT INTERFERING NUCLEIC ACIDS (SINA) CONJUGATED TO A LIPOPHILIC MOIETY Sirna Therapeutics, Inc. (US) 2016-09-21 EP disclosed
EP-3065783-A2 DUAL MOLECULAR DELIVERY OF OLIGONUCLEOTIDES AND PEPTIDE CONTAINING CONJUGATES Merck Sharp & Dohme Corp. (US) 2016-09-14 EP disclosed
EP-3065758-A2 PEPTIDE CONTAINING CONJUGATES FOR DUAL MOLECULAR DELIVERY OF OLIGONUCLEOTIDES Merck Sharp & Dohme Corp. (US) 2016-09-14 EP disclosed
US-20160256570-A1 SYSTEMIC DELIVERY OF MYOSTATIN SHORT INTERFERING NUCLEIC ACIDS (siNA) CONJUGATED TO A LIPOPHILIC MOIETY SIRNA THERAPEUTICS, INC. (US) 2016-09-08 US disclosed
EP-2114885-B1 PROCESS FOR THE OXIDATION OF CERTAIN SUBSTITUTED SULFILIMINES TO INSECTICIDAL SULFOXIMINES DOW AGROSCIENCES LLC (US) 2016-01-27 EP disclosed
US-20150361063-A1 TREATMENT OF AMYLOIDOSIS BY COMPOUNDS THAT REGULATE RETROMER STABILIZATION THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2015-12-17 US disclosed
WO-2015100004-A1 CONTROL OF SUSTAINED CASING PRESSURE IN WELLBORE ANNULI ALBEMARLE CORPORATION (US) 2015-07-02 WO disclosed
WO-2015069586-A2 DUAL MOLECULAR DELIVERY OF OLIGONUCLEOTIDES AND PEPTIDE CONTAINING CONJUGATES MERCK SHARP & DOHME CORP. (US) 2015-05-14 WO disclosed
WO-2015070158-A1 SYSTEMIC DELIVERY OF MYOSTATIN SHORT INTERFERING NUCLEIC ACIDS (SINA) CONJUGATED TO A LIPOPHILIC MOIETY SIRNA THERAPEUTICS, INC. (US) 2015-05-14 WO disclosed
WO-2015069587-A2 PEPTIDE CONTAINING CONJUGATES FOR DUAL MOLECULAR DELIVERY OF OLIGONUCLEOTIDES MERCK SHARP & DOHME CORP. (US) 2015-05-14 WO disclosed
US-9012463-B2 Inhibitors of bruton's tyrosine kinase PHARMACYCLICS, INC. (US) 2015-04-21 US disclosed
EP-2492261-B1 Analogs of benzoquinone-containing ansamycins for the treatment of cancer INFINITY DISCOVERY INC (US) 2015-02-18 EP disclosed
EP-2787990-A1 TREATMENT OF AMYLOIDOSIS BY COMPOUNDS THAT REGULATE RETROMER STABILIZATION Brandeis University (US) 2014-10-15 EP disclosed
US-20140288145-A1 TREATMENT OF AMYLOIDOSIS BY COMPOUNDS THAT REGULATE RETROMER STABILIZATION BRANDEIS UNIVERSITY (US) 2014-09-25 US disclosed
US-20140235707-A1 METHODS AND COMPOSITIONS FOR PREDICTING RESPONSE TO ERIBULIN EISAI R&D MANAGEMENT CO., LTD. (JP) 2014-08-21 US disclosed
US-20140080844-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE PHARMACYCLICS, INC. (US) 2014-03-20 US disclosed
WO-2013171755-A2 \"COMBUSTION SYNTHESIS OF NANOCRYSTALLINE ALKALI AND ALKALINE EARTH METAL OXIDES OR MIXTURE THEREOF AND ITS APPLICATIONS IN SYNTHESIS OF [4- (ALKYL/ARYL)-OXY- 1,3 -DIOXOLANE-2- ONE] AND 2-OXAZOLIDINONES\ YADAV GANAPATI DADASAHEB (IN) 2013-11-21 WO disclosed
WO-2013085877-A1 TREATMENT OF AMYLOIDOSIS BY COMPOUNDS THAT REGULATE RETROMER STABILIZATION BRANDEIS UNIVERSITY (US) 2013-06-13 WO disclosed
US-8455568-B2 Lubricating oil additive composition and method of making the same CHEVRON ORONITE COMPANY LLC (US) 2013-06-04 US disclosed
CN-103122019-A Compounds useful for treating neurodegenerative disorders SATORI PHARMACEUTICALS INC 2013-05-29 CN disclosed
WO-2013036665-A1 COMPOUNDS FOR USE IN TREATING NEURODEGENERATIVE DISORDERS, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO SATORI PHARMACEUTICALS, INC. (US) 2013-03-14 WO disclosed
US-20130060019-A1 Compounds for Use in Treating Neurodegenerative Disorders, Synthesis Thereof, and Intermediates Thereto SATORI PHARMACEUTICALS, INC. (US) 2013-03-07 US disclosed
US-20130060013-A1 Compounds useful for treating neurodegenerative disorders SATORI PHARMACEUTICALS, INC. (US) 2013-03-07 US disclosed
CN-102675151-A Preparation method of nitrophenylacetonitrile compound BEIJING YINGTAI JIAHE BIOLOG TECHNOLOGY CO LTD 2012-09-19 CN disclosed
EP-2272839-B1 Intermediate compounds for the preparation of halichondrin analogs EISAI R&D MAN CO LTD (JP) 2012-08-22 EP disclosed
EP-2272840-B1 Intermediate compound for the preparation of halichondrin analogs EISAI R&D MAN CO LTD (JP) 2012-08-22 EP disclosed
EP-2277873-B1 Intermediate compound for the preparation of halichondrin analogs EISAI R&D MAN CO LTD (JP) 2012-05-30 EP disclosed
EP-1882729-B1 Modified copolymer containing lubricating oil additive composition and method of making the same CHEVRON ORONITE CO (US) 2012-05-02 EP disclosed
EP-1927650-B1 Modified copolymer containing lubricating oil additive composition and method of making the same CHEVRON ORONITE CO (US) 2012-05-02 EP disclosed
EP-1916292-B1 Modified copolymer containing lubricating oil additive composition and method of making the same CHEVRON ORONITE CO (US) 2011-11-16 EP disclosed
US-20110262653-A1 Method of Producing Color Change in a Web Substrate THE PROCTER & GAMBLE COMPANY 2011-10-27 US disclosed
US-20110251379-A1 COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS SATORI PHARMACEUTICALS, INC. (US) 2011-10-13 US disclosed
EP-1760138-B1 Modified copolymer containing lubricating oil additive composition and method of making the same CHEVRON ORONITE CO (US) 2011-09-14 EP disclosed
EP-1916293-B1 Modified copolymer containing lubricating oil additive composition and method of making the same CHEVRON ORONITE CO (US) 2011-08-03 EP disclosed
EP-1916290-B1 Modified copolymer containing lubricating oil additive composition and method of making the same CHEVRON ORONITE CO (US) 2011-08-03 EP disclosed
EP-1921128-B1 Modified copolymer containing lubricating oil additive composition and method of making the same CHEVRON ORONITE CO (US) 2011-08-03 EP disclosed
EP-1925658-B1 Modified copolymer containing lubricating oil additive composition and method of making the same CHEVRON ORONITE CO (US) 2011-08-03 EP disclosed
US-20110136749-A1 COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS SATORI PHARMACEUTICALS, INC. (US) 2011-06-09 US disclosed
US-20110136750-A1 COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS SATORI PHARMACEUTICALS, INC. (US) 2011-06-09 US disclosed
US-7928044-B2 Reacting copolymer comprised of ethylenically unsaturated comonomers with polyether aromatic compound; free radical catalysis; dispersants in internal combustion engines; block polymerization; addition-condensation polymerization CHEVRON ORONITE COMPANY LLC (US) 2011-04-19 US disclosed
EP-1087960-B1 MACROCYCLIC ANALOGS AND METHODS OF THEIR USE AND PREPARATION EISAI R&D MAN CO LTD (JP) 2011-03-23 EP disclosed
WO-2011021398-A1 SUGAR DERIVATIVE HAVING A POLYMERIZABLE GROUP, AND RESIST MATERIAL USING SAID SUGAR DERIVATIVE 出光興産株式会社 (JP) 2011-02-24 WO disclosed
EP-2277873-A1 Intermediate compound for the preparation of halichondrin analogs Eisai R&D Management Co., Ltd. (JP) 2011-01-26 EP disclosed
EP-2271733-A2 A LUBRICATING OIL ADDITIVE COMPOSITION AND METHOD OF MAKING THE SAME Chevron Oronite Company LLC (US) 2011-01-12 EP disclosed
EP-2272840-A1 Intermediate compound for the preparation of halichondrin analogs Eisai R&D Management Co., Ltd. (JP) 2011-01-12 EP disclosed
EP-2272839-A1 Intermediate compounds for the preparation of halichondrin analogs Eisai R&D Management Co., Ltd. (JP) 2011-01-12 EP disclosed
US-7863390-B2 Esterified copolymers of polyalkenes/unsaturated acidic reagents useful as lubricant and fuel additives Chevron Oronise Company LLC (US) 2011-01-04 US disclosed
US-7858566-B2 Lubricating oil additive composition and method of making the same CHEVRON ORONITE COMPANY LLC (US) 2010-12-28 US disclosed
US-7851641-B2 Compounds useful for treating neurodegenerative disorders SATORI PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed
US-7820604-B2 Lubricating oil additive composition and method of making the same CHEVRON ORONITE COMPANY LLC (US) 2010-10-26 US disclosed
US-7820605-B2 Lubricating oil additive composition and method of making the same CHEVRON ORONITE COMPANY LLC (US) 2010-10-26 US disclosed
US-7816309-B2 Lubricating oil additive composition and method of making the same CHEVRON ORONITE COMPANY LLC (US) 2010-10-19 US disclosed
US-7745541-B2 Lubricating oil additive composition and method of making the same CHEVRON ORONITE COMPANY LLC (US) 2010-06-29 US disclosed
US-7745542-B2 Lubricating oil additive composition and method of making the same CHEVRON ORONITE COMPANY LLC (US) 2010-06-29 US disclosed
US-20100144689-A1 COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS SATORI PHARMACEUTICALS, INC. (US) 2010-06-10 US disclosed
US-7674863-B2 Esterified copolymers of polyalkenes/unsaturated acidic reagents useful as lubricant and fuel additives CHEVRON ORONITE COMPANY LLC (US) 2010-03-09 US disclosed
CN-101610673-A Compounds useful for the treatment of neurodegenerative disorders SARTORI PHARMACEUTICAL INC (US) 2009-12-23 CN disclosed
US-7618928-B2 Lubricating oil additive composition and method of making the same CHEVRON ORONITE COMPANY LLC (US) 2009-11-17 US disclosed
EP-1931341-B1 1H-INDOLE-PYRIDINECARBOXAMIDE AND 1H-INDOLE-PIPERIDINECARBOXAMIDE DERIVATIVES AND THEIR USE AS TYROSINE HYDROXYLASE INDUCERS SERVIER LAB (FR) 2009-11-04 EP disclosed
US-20090270531-A1 LUBRICATING OIL ADDITIVE COMPOSITION AND METHOD OF MAKING THE SAME CHEVRON ORONITE COMPANY LLC 2009-10-29 US disclosed
WO-2009132250-A2 A LUBRICATING OIL ADDITIVE COMPOSITION AND METHOD OF MAKING THE SAME CHEVRON ORONITE COMPANY LLC (US) 2009-10-29 WO disclosed
US-20090258883-A1 1H-Indole-Pyridinecarboxamide and 1H-Indole-Piperidinecarboxamide Compounds LES LABORATOIRES SERVIER (FR) 2009-10-15 US disclosed
WO-2009103022-A1 DERIVATIVES OF SUBSTITUTED FUSED RING CYCLOINDOLES AND METHODS OF THEIR USE ITHERX PHARMACEUTICALS, INC. (US) 2009-08-20 WO disclosed
US-20090181869-A1 Esterified copolymers of polyalkenes/unsaturated acidic reagents useful as lubricant and fuel additives CHEVRON ORONITE COMPANY LLC (US) 2009-07-16 US disclosed
WO-2008146064-A1 NEW BENZOFURAN DERIVATIVES AS SELECTIVE 5HT7 RECEPTOR INHIBITORS AND PROCESS FOR THEIR PREPARATION EGIS GYÓGYSZERGYÁR (HU) 2008-12-04 WO disclosed
EP-1491561-B1 Esterified copolymers of polyalkenes/unsaturated acidic reagents useful as lubricant and fuel additives CHEVRON ORONITE CO (US) 2008-10-29 EP disclosed
CN-101223185-A Compounds for the treatment of neurodegenerative disorders SATORI PHARMACEUTICALS INC (US) 2008-07-16 CN disclosed
EP-1931341-A2 NOVEL 1H-INDOLE-PYRIDINECARBOXAMIDE DERIVATIVES AND 1H-INDOLE-PIPERIDINECARBOXAMIDE AND THEIR USE AS HYDROXALASE TYROSINE INDUCERS Les Laboratoires Servier (FR) 2008-06-18 EP disclosed
EP-1927650-A1 A lubricating oil additive composition and method of making the same Chevron Oronite Company LLC (US) 2008-06-04 EP disclosed
EP-1925658-A1 A lubricating oil additive composition and method of making the same Chevron Oronite Company LLC (US) 2008-05-28 EP disclosed
WO-2008058111-A2 METHODS OF PREPARING HALOHYDROXYPROPYLTRIALKYLAMMONIUM HALIDES DOW GLOBAL TECHNOLOGIES INC. (US) 2008-05-15 WO disclosed
US-20080113888-A1 LUBRICATING OIL ADDITIVE COMPOSITION AND METHOD OF MAKING THE SAME CHEVRON ORONITE COMPANY LLC 2008-05-15 US disclosed
EP-1921128-A1 A lubricating oil additive composition and method of making the same Chevron Oronite Company LLC (US) 2008-05-14 EP disclosed
US-20080103075-A1 LUBRICATING OIL ADDITIVE COMPOSITION AND METHOD OF MAKING THE SAME CHEVRON ORONITE COMPANY LLC 2008-05-01 US disclosed
US-20080103236-A1 LUBRICATING OIL ADDITIVE COMPOSITION AND METHOD OF MAKING THE SAME CHEVRON ORONITE COMPANY LLC 2008-05-01 US disclosed
US-20080103076-A1 LUBRICATING OIL ADDITIVE COMPOSITION AND METHOD OF MAKING THE SAME CHEVRON ORONITE COMPANY LLC 2008-05-01 US disclosed
US-20080103074-A1 LUBRICATING OIL ADDITIVE COMPOSITION AND METHOD OF MAKING THE SAME CHEVRON ORONITE COMPANY LLC 2008-05-01 US disclosed
EP-1916290-A1 A lubricating oil additive composition and method of making the same Chevron Oronite Company LLC (US) 2008-04-30 EP disclosed
EP-1916292-A1 A lubricating oil additive composition and method of making the same Chevron Oronite Company LLC (US) 2008-04-30 EP disclosed
EP-1916293-A1 A lubricating oil additive composition and method of making the same Chevron Oronite Company LLC (US) 2008-04-30 EP disclosed
EP-1882729-A2 A lubricating oil additive composition and method of making the same Chevron Oronite Company LLC (US) 2008-01-30 EP disclosed
US-20080009427-A1 Esterified copolymers of polyalkenes/unsaturated acidic reagents useful as lubricant and fuel additives CHEVRON ORONITE COMPANY, LLC (US) 2008-01-10 US disclosed
US-7256242-B2 Esterified copolymers of polyalkenes/unsaturated acidic reagents useful as lubricant and fuel additives CHEVRON ORONITE COMPANY, LLC (US) 2007-08-14 US disclosed
US-20070149491-A1 Compounds useful for treating neurodegenerative disorders SATORI PHARMACEUTICALS, INC. 2007-06-28 US disclosed
EP-1760138-A2 A lubricating oil additive composition and method of making the same Chevron Oronite Company LLC (US) 2007-03-07 EP disclosed
US-20070049503-A1 Lubricating oil additive composition and method of making the same CHEVRON ORONITE COMPANY LLC 2007-03-01 US disclosed
US-20070027267-A1 Lubricating oil additive composition and method of making the same CHEVRON ORONITE COMPANY LLC 2007-02-01 US disclosed
WO-2007006922-A2 NOVEL 1H-INDOLE-PYRIDINECARBOXAMIDE DERIVATIVES AND 1H-INDOLE-PIPERIDINECARBOXAMIDE AND THEIR USE AS HYDROXYLASE TYROSINE INDUCERS LES LABORATOIRES SERVIER (FR) 2007-01-18 WO disclosed
US-20070010503-A1 Compounds useful for treating neurodegenerative disorders LIGHTHOUSE CAPITAL PARTNERS VI, L.P. 2007-01-11 US disclosed
EP-1717300-A1 A lubricating oil additive composition and method of making the same Chevron Oronite Company LLC (US) 2006-11-02 EP disclosed
US-20060247386-A1 Lubricating oil additive composition and method of making the same CHEVRON ORONITE COMPANY LLC. 2006-11-02 US disclosed
EP-0894102-B8 COPOLYMERS OF HIGH VINYLIDENE POLYOLEFINS WITH VINYL OR VINYLIDENE MONOMERS PRODUCED BY FREE RADICAL POLYMERIZATION O & D USA LLC (US) 2006-01-18 EP disclosed
EP-0894102-B1 COPOLYMERS OF HIGH VINYLIDENE POLYOLEFINS WITH VINYL OR VINYLIDENE MONOMERS PRODUCED BY FREE RADICAL POLYMERIZATION BP CORP NORTH AMERICA INC (US) 2005-11-16 EP disclosed
US-20050238589-A1 Methods and compositions for preventing or treating periodontal diseases NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-10-27 US disclosed
EP-1027411-B1 COPOLYMERS OF ETHYLENE ALPHA-OLEFIN MACROMERS AND DICARBOXYLIC MONOMERS AND DERIVATIVES THEREOF, USEFUL AS ADDITIVES IN LUBRICATING OILS AND IN FUELS EXXONMOBIL CHEM PATENTS INC (US) 2005-08-24 EP disclosed
CN-1216051-C Macrocyclic analogs and methods of use and preparation thereof EISAI CO LTD (JP) 2005-08-24 CN disclosed
EP-1498497-A2 Method of nucleic acid analysis by mass spectrometry Cancer Research Technology Limited (GB) 2005-01-19 EP disclosed
US-20040266955-A1 Esterified copolymers of polyalkenes/unsaturated acidic reagents useful as lubricant and fuel additives CHEVRON ORONITE COMPANY LLC 2004-12-30 US disclosed
US-20040256743-A1 Method for producing organic compound by substituting halogen atoms MITSUI CHEMICALS, INC. (JP) 2004-12-23 US disclosed
EP-1486479-A1 Method for producing organic compounds by substituting halogen atoms MITSUI CHEMICALS, INC. (JP) 2004-12-15 EP disclosed
EP-1014999-B1 CATIONIC POLYMERS AS TOXIN-BINDING AGENTS GENZYME CORP (US) 2004-12-08 EP disclosed
EP-0813609-B1 METHOD OF NUCLEIC ACID ANALYSIS CANCER REC TECH LTD (GB) 2004-10-13 EP disclosed
US-6759428-B2 SUCH AS N-((1,2)-2-(((CYANO(CYCLOPROPYL)METHYL)AMINO)CARBONYL) CYCLOHEXYL)-1H-INDOLE-2-CARBOXAMIDE; CATHEPSIN K INHIBITORS ROCHE PALO ALTO LLC 2004-07-06 US disclosed
US-20040077646-A1 Indole nitriles ROCHE PALO ALTO LLC 2004-04-22 US disclosed
US-6692732-B2 Administering cationic polymers to mammals to prevent poisons or antigens from microorganisms such as bacteria, viruses, fungi or parasites; deactivation GENZYME CORPORATION 2004-02-17 US disclosed
US-20040009145-A1 IONIC POLYMERS AS TOXIN-BINDING AGENTS GELTEX PHARMACEUTICALS, INC. 2004-01-15 US disclosed
US-6583228-B2 Waterproofing; impact strength BP CORPORATION NORTH AMERICA INC. 2003-06-24 US disclosed
EP-0657475-B1 Polymeric dispersants having polyalkylene and succinic groups CHEVRON ORONITE CO (US) 2003-06-04 EP disclosed
US-6545173-B1 Chemical intermediate for sibutramine ABBOTT LABORATORIES 2003-04-08 US disclosed
US-6482402-B1 BACTERICIDE AND CATIONIC POLYMER GELTEX PHARMACEUTICALS, INC. 2002-11-19 US disclosed
US-20020161156-A1 COPOLYMERS OF HIGH VINYLIDENE POLYOLEFINS WITH VINYL OR VINYLIDENE MONOMERS PRODUCED BY FREE RADICAL POLYMERIZATION INEOS USA LLC 2002-10-31 US disclosed
EP-0733696-B1 Lubricating oil dispersants ETHYL PETROLEUM ADDITIVES LTD (GB) 2002-10-30 EP disclosed
US-6469182-B1 HALICHONDRIN ANALOGS HAVING PHARMACEUTICAL ACTIVITY, SUCH AS ANTICANCER OR ANTIMITOTIC ACTIVITY EISAI CO., LTD. (JP) 2002-10-22 US disclosed
US-20020114774-A1 Ionic polymers as toxin-binding agents GELTEX PHARMACEUTICALS, INC. 2002-08-22 US disclosed
US-6365759-B1 ANTICARCINOGENIC AND ANTIMITOTIC AGENTS; STABLE; MELANOMA; LEUKEMIA; COLON; MAMMARY GLANDS; OVARIES; PROSTATE GLANDS; LUNGS EISAI CO., LTD. (JP) 2002-04-02 US disclosed
EP-1027411-A4 COPOLYMERS OF ETHYLENE $g(a)-OLEFIN MACROMERS AND DICARBOXYLIC MONOMERS AND DERIVATIVES THEREOF, USEFUL AS ADDITIVES IN LUBRICATING OILS AND IN FUELS EXXONMOBIL CHEM PATENTS INC (US) 2001-10-10 EP disclosed
US-6290947-B1 IN ONE EMBODIMENT, THE POLYMER IS A COPOLYMER COMPRISING A MONOMER HAVING A PENDANT AMMONIUM GROUP AND A HYDROPHOBIC MONOMER. GELTEX PHARMACEUTICALS, INC. 2001-09-18 US disclosed
CN-1312804-A Macrocyclic analogs and methods of their use and preparation EISAI CO LTD (JP) 2001-09-12 CN disclosed
US-6268129-B1 MASS SPECTROMETRY OF CHARGED NUCLEIC ACID; DNA SEQUENCING IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2001-07-31 US disclosed
US-6214865-B1 Macrocyclic analogs and methods of their use and preparation EISAI CO., LTD. (JP) 2001-04-10 US disclosed
EP-0863868-B1 PROCESS FOR THE PREPARATION OF 1-ARYL-1-CYANOCYCLOBUTANE DERIVATIVES KNOLL AG (DE) 2001-02-21 EP disclosed
EP-0710684-B1 Preparation process of polyhydroxycarboxylic acid MITSUI CHEMICALS INC (JP) 2001-01-31 EP disclosed
US-6111027-A AN ADHESIVE COMPRISING A COPOLYMER CONTAINING UNITS DERIVED FROM ONE OR MORE MACROMONOMERS SUCH AS A COPOLYMER OF ETHYLENE-ALPHA OLEFIN OR PROPYLENE-ALPHA OLEFIN WITH AN UNSATURATED ACID OR ANHYDRIDE, AND A TACKIFIER RESIN EXXON CHEMICAL PATENTS, INC (US) 2000-08-29 US disclosed
EP-1027411-A1 COPOLYMERS OF ETHYLENE $g(a)-OLEFIN MACROMERS AND DICARBOXYLIC MONOMERS AND DERIVATIVES THEREOF, USEFUL AS ADDITIVES IN LUBRICATING OILS AND IN FUELS EXXON CHEMICAL PATENTS INC. (US) 2000-08-16 EP disclosed
US-6100224-A DERIVATIZED BY REACTION WITH NUCLEOPHILIC REACTANTS INCLUDING MONOAMINES, POLYAMINES, MONOALCOHOLS, POLYOLS ETC.; DISPERSANTS; DETERGENTS; MULTIFUNCTIONAL VISCOSITY INDEX IMPROVER ADDITIVES; CRYSTAL GROWTH INHIBITORS; TEMP. BALANCE EXXON CHEMICAL PATENTS INC (US) 2000-08-08 US disclosed
EP-1023418-A1 ADHESIVES COMPRISING COPOLYMERS OF MACROMONOMERS AND UNSATURATED ACIDS OR ANHYDRIDES EXXON CHEMICAL PATENTS INC. (US) 2000-08-02 EP disclosed
EP-1014999-A1 CATIONIC POLYMERS AS TOXIN-BINDING AGENTS GELTEX PHARMACEUTICALS, INC. (US) 2000-07-05 EP disclosed
EP-0733697-B1 Post-treated dispersants ETHYL PETROLEUM ADDITIVES LTD (GB) 2000-05-10 EP disclosed
US-6007803-A ADMINISTERING TO MAMMAL A CATIONIC POLYMER TO INHIBIT PATHOGENIC TOXINS GELTEX PHARMACEUTICALS, INC. (US) 1999-12-28 US disclosed
WO-1999016845-A1 ADHESIVES COMPRISING COPOLYMERS OF MACROMONOMERS AND UNSATURATED ACIDS OR ANHYDRIDES EXXON CHEMICAL PATENTS INC. (US) 1999-04-08 WO disclosed
WO-1999016851-A1 COPOLYMERS OF ETHYLENE α-OLEFIN MACROMERS AND DICARBOXYLIC MONOMERS AND DERIVATIVES THEREOF, USEFUL AS ADDITIVES IN LUBRICATING OILS AND IN FUELS EXXON CHEMICAL PATENTS INC. (US) 1999-04-08 WO disclosed
WO-1999015186-A1 CATIONIC POLYMERS AS TOXIN-BINDING AGENTS GELTEX PHARMACEUTICALS, INC. (US) 1999-04-01 WO disclosed
US-5871670-A Electroconductive composition CIBA SPECIALTY CHEMICALS CORPORATION (US) 1999-02-16 US disclosed
EP-0894102-A1 COPOLYMERS OF HIGH VINYLIDENE POLYOLEFINS WITH VINYL OR VINYLIDENE MONOMERS PRODUCED BY FREE RADICAL POLYMERIZATION AMOCO CORPORATION (US) 1999-02-03 EP disclosed
EP-0863868-A1 PROCESS FOR THE PREPARATION OF 1-ARYL-1-CYANOCYCLOBUTANE DERIVATIVES KNOLL AKTIENGESELLSCHAFT (DE) 1998-09-16 EP disclosed
WO-1998037112-A1 COPOLYMERS OF HIGH VINYLIDENE POLYOLEFINS WITH VINYL OR VINYLIDENE MONOMERS PRODUCED BY FREE RADICAL POLYMERIZATION AMOCO CORPORATION (US) 1998-08-27 WO disclosed
EP-0735870-A4 USE OF PLA 2? INHIBITORS AS TREATMENT FOR ALZHEIMER'S DISEASE LILLY CO ELI (US) 1998-08-19 EP disclosed
US-5770683-A Preparation process of polyhydroxycarboxylic acid MITSUI TOATSU CHEMICALS, INC. (JP) 1998-06-23 US disclosed
EP-0813609-A1 METHOD OF NUCLEIC ACID ANALYSIS IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) 1997-12-29 EP disclosed
EP-0782750-A1 NOVEL ELECTROCONDUCTIVE COMPOSITION Ciba SC Holding AG (CH) 1997-07-09 EP disclosed
WO-1997020810-A1 PROCESS FOR THE PREPARATION OF 1-ARYL-1-CYANOCYCLOBUTANE DERIVATIVES KNOLL AKTIENGESELLSCHAFT (DE) 1997-06-12 WO disclosed
US-5616668-A OIL ADDITIVE CHEVRON CHEMICAL COMPANY (US) 1997-04-01 US disclosed
US-5565528-A COPOLYMER OF UNSATURATED ACIDIC REACTANT AND HIGH MOLECULAR WEIGHT OLEFIN REACTED WITH POLYAMINE CHEVRON CHEMICAL COMPANY (US) 1996-10-15 US disclosed
EP-0735870-A1 USE OF PLA 2? INHIBITORS AS TREATMENT FOR ALZHEIMER'S DISEASE ELI LILLY AND COMPANY (US) 1996-10-09 EP disclosed
US-5563164-A TREATING ARTHRITIS, PSORIASIS, ASTHMA, INFLAMMATORY BOWEL DISEASE, OR ALZHEIMER'S DISEASE ELI LILLY AND COMPANY (US) 1996-10-08 US disclosed
EP-0733696-A1 Lubricating oil dispersants ETHYL PETROLEUM ADDITIVES LIMITED (GB) 1996-09-25 EP disclosed
EP-0733697-A1 Post-treated dispersants ETHYL PETROLEUM ADDITIVES LIMITED (GB) 1996-09-25 EP disclosed
WO-1996027681-A1 METHOD OF NUCLEIC ACID ANALYSIS IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) 1996-09-12 WO disclosed
US-5552441-A ANTIALLERGENS, ANTIINFLAMMATORY AGENTS AND RESPIRATORY SYSTEM DISORDERS ELI LILLY AND COMPANY (US) 1996-09-03 US disclosed
EP-0710684-A2 Preparation process of polyhydroxycarboxylic acid MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-05-08 EP disclosed
WO-1996009629-A1 NOVEL ELECTROCONDUCTIVE COMPOSITION CIBA SPECIALTY CHEMICALS HOLDIING INC (CH) 1996-03-28 WO disclosed
US-5478857-A Administering inhibitor of phospholipase A2 ELI LILLY AND COMPANY (US) 1995-12-26 US disclosed
EP-0362141-B1 Electrically conductive support and polymer films, and process for manufacturing the same CIBA GEIGY AG (CH) 1995-11-15 EP disclosed
EP-0362143-B1 Antistatic and electrically conductive relief images, process for manufacturing the same, coating material and radiation-sensitive polymers CIBA GEIGY AG (CH) 1995-11-15 EP disclosed
WO-1995017183-A1 USE OF PLA2 INHIBITORS AS TREATMENT FOR ALZHEIMER'S DISEASE ELI LILLY AND COMPANY (US) 1995-06-29 WO disclosed
EP-0657475-A1 Polymeric dispersants having polyalkylene and succinic groups CHEVRON CHEMICAL COMPANY (US) 1995-06-14 EP disclosed
EP-0387346-B1 NOVEL POLYMERIC DISPERSANTS HAVING ALTERNATING POLYALKYLENE AND SUCCINIC GROUPS CHEVRON USA INC (US) 1995-06-14 EP disclosed
EP-0521826-B1 Process for the production of electroconductive layers CIBA GEIGY AG (CH) 1995-06-07 EP disclosed
US-5348762-A Process for the production of conductive layers CIBA-GEIGY CORPORATION (US) 1994-09-20 US disclosed
EP-0373104-B1 Etherified fluorescein compounds CIBA GEIGY AG (CH) 1994-07-13 EP disclosed
US-5324743-A Leukotriene B4 antagonists ELI LILLY AND COMPANY (US) 1994-06-28 US disclosed
EP-0575303-A1 A process for the preparation of 5-(2,5-dimethyl-phenoxy)-2,2-dimethyl pentanoic acid S.A. OMNICHEM N.V. (BE) 1993-12-22 EP disclosed
EP-0521826-A1 Process for the production of electroconductive layers CIBA-GEIGY AG (CH) 1993-01-07 EP disclosed
US-5153321-A Tetrathionaphthalene, tetraselenonaphthalene, tetratelluro-naphthalene, tetrathiotetracene, tetraselenotetracene, or tetratellurotetracene compounds for charge-transfer complexes CIBA-GEIGY CORPORATION (US) 1992-10-06 US disclosed
US-5112507-A Imidized isobutylene-maleic anhydride copolymer, branching, oil and fuel dispersant CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1992-05-12 US disclosed
EP-0285564-B1 ANTISTATIC AND ELECTRICALLY CONDUCTIVE POLYMERS AND MOULDING COMPOSITIONS CIBA-GEIGY AG (CH) 1992-04-15 EP disclosed
US-5096780-A ELECTRICALLY CONDUCTIVE COATING COMPRISING A NEEDLE NETWORK OF CHANGE TRANSFER COMPLEXES CIBA-GEIGY CORPORATION (US) 1992-03-17 US disclosed
US-5084456-A Analgesics SCIENCE ET ORGANISATION (FR) 1992-01-28 US disclosed
EP-0467325-A2 Carbostyril derivatives SYNTEX (U.S.A.) INC. (US) 1992-01-22 EP disclosed
US-5082847-A Antiarrhythmia SYNTEX (U.S.A.) INC. (US) 1992-01-21 US disclosed
US-5077156-A ANTISTATIC AND ELECTRICALLY CONDUCTIVE RELIEF IMAGES, PROCESSES FOR THE PRODUCTION THEREOF, COATING AGENTS AND RADIATION-SENSITIVE POLYMERS CIBA-GEIGY CORPORATION (US) 1991-12-31 US disclosed
US-5055595-A ETHERIFIED FLUORESCEIN COMPOUNDS CIBA-GEIGY CORPORATION (US) 1991-10-08 US disclosed
US-5009812-A Forming charge transfer complexes CIBA-GEIGY CORPORATION (US) 1991-04-23 US disclosed
EP-0387346-A4 NOVEL POLYMERIC DISPERSANTS HAVING ALTERNATING POLYALKYLENE AND SUCCINIC GROUPS 1991-04-10 EP disclosed
EP-0387346-A1 NOVEL POLYMERIC DISPERSANTS HAVING ALTERNATING POLYALKYLENE AND SUCCINIC GROUPS. CHEVRON RES (US) 1990-09-19 EP disclosed
EP-0373104-A1 Etherified fluorescein compounds CIBA-GEIGY AG (CH) 1990-06-13 EP disclosed
WO-1990003359-A1 NOVEL POLYMERIC DISPERSANTS HAVING ALTERNATING POLYALKYLENE AND SUCCINIC GROUPS CHEVRON RESEARCH COMPANY (US) 1990-04-05 WO disclosed
EP-0352530-A2 Substituted tricyclic compounds, process for their preparation and their use as insecticides BAYER AG (DE) 1990-01-31 EP disclosed
EP-0296622-A2 Derivatives of poly(diallyl-methylamine) and their use as cholesterol-lowering agents HERCULES INCORPORATED (US) 1988-12-28 EP disclosed
US-4759923-A Orally administering to the animal therapeutical amount of quaternized crosslinked polydiallylmethylamine HERCULES INCORPORATED (US) 1988-07-26 US disclosed
EP-0171762-A2 Process for preparing carboxylate esters AIR PRODUCTS AND CHEMICALS, INC. (US) 1986-02-19 EP disclosed
US-4269992-A REFLUXING A POLYDIHYDROCARBON SILOXANE CONTAINING HALOGEN GROUPS AND AN ALCOHOL-MODIFIED POLYOXYALKYLENE GLYCOL IN A SOLVENT OF AN ALKYL OR ALKENYL HALIDE UNION CARBIDE CORPORATION (US) 1981-05-26 US disclosed
US-4147556-A Nonflammable beta diketonate composition PPG INDUSTRIES, INC. (US) 1979-04-03 US disclosed
US-4134975-A PYRIDO(1,2,-D)(1,4,6)BENZOXADIAZOCINES OR PYRIDO(1,2,-C)(1,3,5)BENZOXADIAZEPINES E. R. SQUIBB & SONS, INC. (US) 1979-01-16 US disclosed
US-3965101-A CNS STIMULANTS E. R. SQUIBB & SONS, INC. (US) 1976-06-22 US disclosed
US-3957806-A STIMULANTS, MUSCLE RELAXANTS E. R. SQUIBB & SONS, INC. (US) 1976-05-18 US disclosed
US-3941827-A Preparation of halogenated nitriles MICHIGAN CHEMICAL CORPORATION (US) 1976-03-02 US disclosed
US-3941827-A Preparation of halogenated nitriles MICHIGAN CHEMICAL CORPORATION (US) 1976-03-02 US disclosed